| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |